Fc Fusion Protein Market: Global Market Size, Share, Growth, Trends, and Forecast

The Fc Fusion Protein Market is expanding as Fc fusion biologics gain increasing importance across autoimmune, ophthalmic, rare-disease, and other therapeutic applications.

According to Market Research Future, the global market was valued at USD 48.30 billion in 2025 and is projected to reach USD 87.10 billion by 2035, registering a CAGR of 6.1% during 2026–2035.

Fc fusion proteins combine the therapeutic properties of functional protein domains with the Fc region of immunoglobulins. This approach can improve pharmacokinetic characteristics, including serum half-life, while supporting the development of targeted biologic therapies.

North America currently represents the largest regional market, accounting for approximately 37.5% of market revenue. Asia-Pacific is expected to be the fastest-growing region, supported by expanding biologics manufacturing capabilities and healthcare investment.

The increasing adoption of engineered Fc domains, biosimilar development, and next-generation biologic therapies is expected to create additional opportunities for market participants through 2035.